You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 5, May 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypersensitivity to Deoxyribonucleic Acid In Cutaneous Disease

RICHARD W. FARDAL, MD; R. K. WINKELMANN, MD

Arch Dermatol. 1965;91(5):503-511.


Abstract

Forty of 115 patients reacted to intradermal deoxyribonucleic acid (DNA), demonstrating erythema, edema, and induration of the test site within 24 hours; an additional four patients reacted to the original antigen but not a new one. Positive reactions were about twice as frequent in untreated patients as in patients with similar disease who were receiving steroid or antimalarial drugs. Five patients were tested before and after such therapy; in each instance the reaction was abolished or diminished. No correlation seemed to exist between reaction to DNA and the presence of the LE or the rheumatoid factor, or the duration of severity of the disease.

Serum was obtained from ten consecutive unselected patients and from five additional, selected patients with necrotizing vasculitis. An immunodiffusion agar technique did not demonstrate precipitating factors directed against DNA in these 15 sera. An indirect immunofluorescent technique employing the same sera demonstrated antinuclear factors in all patients with systemic lupus erythematosis (SLE) and disseminated lupus erythematosus (DLE) and in one paltient with necrotizing (allergic) vasculitis.

There is no conclusive evidence that hypersensitivity to DNA exists in collagen diseases, necrotizing vasculitis, and other nonsuppurative inflammatory diseases studied. Intraderma testing employing DNA is a moderately sensitive but poorly specific means for detecting apparent delayed (cellular) hypersensitivity to nucleoprotein. However, one must not imply that such hypersensitivity, if it exists, is essential to the diseases studied. The test may have some merit in screening large population groups but lacks reliability since some patients with clinically active, untreated disease do not react.



Author Affiliations

ROCHESTER, MINN

From the Mayo Clinic and Mayo Foundation. Fellow in Dermatology (Dr. Fardal) and Section of Dermatology (Dr. Winkelmann).


Footnotes

Accepted for publication Dec 14, 1964.

Abridgment of thesis submitted by Dr. Fardal to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Dermatology.

Reprint request to Mayo Clinic, Rochester, Minn 55901.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Guide to the Problem of Photosensitivity
Kalivas
JAMA 1969;209:1706-1709.
ABSTRACT  

Skin Tests With Nuclear Factors in Systemic Lupus Erythematosus
Jones et al.
Arch Dermatol 1967;95:559-564.
ABSTRACT  

Pseudo DNA Autosensitivity: A Factitial Disease
Anderson and McCaffree
JAMA 1966;196:104-105.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.